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 Abstract 
 
Background: Medication mismanagement is a continuous problem particularly in older 
people. Numerous interventions have been developed and tested in an attempt to improve 
adherence with medication in this client group. 
Objectives: This review aimed to examine the simple to complex interventions that have 
been used to assess and improve adherence with medication in older people. 
Design: An extensive review of the literature was performed and 20 relevant research 
papers and one report were chosen. 
Findings: Research papers were evaluated according to design, RCTs were analysed 
using the JADAD scoring system, systematic reviews and reviews of the literature were 
reviewed using the Critical Appraisal Skills Programme and subjected to a narrative 
analysis. This process assisted the development to emerging themes. Four themes were 
developed: patient barriers, health professional involvement, and health related outcomes 
and formation giving. 
Conclusions: The salient findings of the review infer that there is no clear definition of 
non–adherent behavior. Quantitative interventions fail to assess patient choice in relation 
to medication taking. Pharmacist-driven interventions are resource intensive. Health care 
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outcomes and clinical effectiveness are seldom addressed in interventions. Among the 
many difficulties encountered when attempting to use interventions to promote adherence 
with medication in older people is their perceptions and beliefs, the appropriateness of the 
medicines prescribed as well as the impact of lifestyle patterns; smoking, alcohol and 
diet. Many intervention studies are of poor quality and do not include a theoretical 
framework to underpin the interventions being used. More focused research is needed to 
improve understanding of the theoretical knowledge that underpins the complexities of 
adherence with medication in older people. In-depth qualitative studies can be used to 
develop such theory. In addition, the quality of intervention research can be improved by 
the inclusion of a research framework such as the Medical Research Council model. 
 
What is already known about this topic? 
 
• Adherence to medication can vary from 0% to 65% depending on the client population 
• Older people are a vulnerable group due to the adverse effects of aging and increased 
propensity to develop multiple diseases that require pharmacological treatment. 
• Up to 10% of older people are susceptible to unplanned admission to hospital due to 
drug related causes.  
 
What this paper adds 
   
• There is a lack of consensus on how adherence with medication is measured in selective 
diseases. 
 3
• There is a paucity of medication adherence intervention research that has examined 
health care outcomes, clinical efficiency or cost effectiveness. 
• Combined interventions that simplify medicine dosing regimens and use educational 
interventions can be effective in improving adherence with medication in older people. 
• There is a need for more qualitative research that critically examines the complexities of 
adherence to medication in older people. Such examination would enhance current 
comprehension and provide a theoretical framework for intervention studies. 
 
 Key words: older people, adherence with medication, medication interventions, health 
related outcomes, information sharing.  
  
Introduction 
 The most common healthcare intervention is the prescription of medicines. In 2004, 686 
million NHS prescriptions were dispensed in England with an estimated cost of 8 billion 
pounds (Horne et al., 2005). Even though medicines are used as therapeutic agents in the 
management of long term conditions, it is estimated that 30% to 50% of prescribed 
medicines are not taken as recommended. This can create problems for both patients and 
the National Health Service (NHS) in England due to poor management of conditions.     
 
Adherence with medication is a complex and intriguing behavioural issue which has been 
the focus of much debate. Horne et al., (2005) define adherence “as the extent to which 
the patients’ behavior matches agreed recommendations for the prescriber” (p.12). 
Possible influential factors include anthropological, psychological, biomedical 
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parameters as well as the patients’ perceptions of illness (Higgins & Regan, 2004) and 
medication beliefs. Health beliefs are thought to be a useful indicator of adherence and a 
more powerful predictor of medication adherence than either clinical or 
sociodemographic variables (Horne & Weinman, 1999). In one study they accounted for 
22% of the variance in medication adherence in patients with long-term conditions 
(Phatak & Thomas, 2006). If patient’s symptoms disappear, they may mistakenly feel 
that they are cured and no longer require treatment (Kjellgren et al., 1995).  In this case it 
is important to identify the patient’s views on the duration of their treatment.  
 
Non-adherence with medication is not a new issue. Often patients do not disclose their 
medication taking behaviour. Equally prescribers may be unaware of their patients’ 
medication taking practices. In older people of all ages, non-adherence with medication is 
an increasing problem (Ames, 2001, Gray et al., 2001), particularly among octogenarians 
(Morrell et al., 1997). This may relate to the fact that older people generally have more 
chronic conditions that often require complex pharmacological management involving 
several medicines. In older people estimated rates of adherence with medication range 
from 26% to 59% (van Eijken et al., 2003) but may be as low as 0% (Haynes al., 1996, 
Nicol et al. 1999). These estimates are independent of pathological condition (Dodds et 
al., 2000, Benson & Britten, 2002, Wang et al., 2002, Alm-Roijer, 2004, Krousel-Wood 
et al., 2005, Rubin, 2005). Factors attributed to non-adherence include; access to 
medicines, polypharmacy, multiple morbidity (Hughes, 2004),  undiagnosed dementia 
and alcohol problems (Cooper et al., 2005), complexity of regimens, Donnan et al., 2002, 
uncertainty about physician instructions (Browne et al. 2001), the risk of adverse drug 
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effects (Cohen ,2001), dexterity problems (Blenkiron (1996), lack of social support 
(Balkrishman, 1998), poor relationship with health care providers (Vik et al., 2003), poor 
communication between prescriber and patient, inadequate follow-up processes, unclear 
medical instructions and inadequate titration of treatment doses (Ellenbecker, 2004, Lin 
& Ciechanowski, 2008, Morris et al., 2006).  The culmination of these effects can result 
in an increased risk of poor therapeutic control of medical conditions, possible 
deterioration of health status and false impressions of medication taking behaviour for the 
prescriber which may result in inappropriate outcome of medication review and possibly 
the prescription of additional medicines to treat existing conditions.  
 
Pound et al., (2005) in a recent meta-ethnography of qualitative studies identified that 
many patients were reluctant to adhere to their medication regimens because they had 
concerns about their medicines. Although this study was not exclusively focused on older 
people, issues raised such as making medicine taking safe and the provision of choice for 
patients are relevant to older people.    
 
Non-adherence with medication can be classified as intentional, often related to the need 
to avoid drug-related adverse effects (Hughes, 2004. Fernando et al., 2006) or 
unintentional related to cognitive or visionary impairment (van Eijken et al., 2003); poor 
cognition (Gray et al., 2001) or due to poor educational achievement or forgetfulness. 
In patients who fail to adhere to prescribed medication regimens, disease management is 
predominantly suboptimal or ineffective; particularly in long term conditions such as 
hypertension (Krousel-Wood et al., 2005. Lowry et al., 2005, Li et al., 2007), heart 
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failure (Rich et al., 1996, Murray et al., 2004), in cases of multiple co-morbidities 
(Bernstein et al., 2001) and in situations where there is discordance between the drugs the 
patient administers and the drugs are actually prescribed (Yang et al., 2001). Medication 
mismanagement in older people often leads to iatrogenic disease, problems gaining 
access to best treatment (Horn et al., 2005) and unplanned admission to hospital. Pearson, 
(2000) identified that circa 10% of unplanned admissions involving older people were 
related to the adverse effects of medicines. This may not be surprising as older people 
receive 45% of the medicines prescribed in England (DH, 2002). In response to the ever 
increasing drug budget and its impact on NHS resources, the current government 
increased investment in practitioner involvement in the management of long-term care 
conditions (DH, 2005). 
 
Numerous instruments have been developed and tested to assess older people’s capacity 
to manage and adhere to their medicines (Girerd et al., 2001, Roter et al., 1998). 
Educational strategies have been used in an attempt to improve adherence with 
medication (Grant et al., 2003). In addition to pharmacy driven care programs that focus 
on educational initiatives along with blood pressure monitoring (Li et al., 2007) and  
pharmacy driven medication review interventions (Royal et al., 2006). 
 
 In their recent review, Farris & Phillips (2008) identified 15 instruments that have been 
developed for this purpose. Each instrument measured aspects of medication 
management but differed on the duration needed to administer the tool. Although five 
instruments were felt to be superior due to their brevity, assessment of numeracy and 
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patient knowledge (Orwig et al, 2006), the instruments did not include measures to 
identify patients with medication mismanagement problems or the support networks that 
patients required in order to self manage medicines. In addition, numerous interventions 
have been developed to improve understanding of the technicalities of non-adherence 
with medication, how to influence and improve it (Sturman-Bieze et al., 2004, Parthan et 
al., 2006, Royal et al., 2006).  Interventions range from minor adjustments to the 
medication regimen to complex, multiphase interventions that promote extended 
pharmacist roles and consider barriers to communication and how to improve health care 
provision (Roter et al., 1998, McDonald et al., 2002).  
 
Many interventions include a wide age range and therefore do not focus specifically on 
older people. Even though non-adherence with medication can have a significant impact 
on health resources and health care costs such as drug budget and costs of unplanned 
hospitalization. It was felt appropriate to focus on this patient population to examine what 
impact adherence interventions may have in this population of patients. The aim of this 
review is to examine the available literature on interventions used to improve adherence 
with medication in older people.  
 
 Method  
This review draws on established methods to review the literature (CRD, 2001). This 
review attempts to evaluate a range of existing research that is relevant to interventions 
that have been used to improve adherence with medication in older people populations. 
The aim of this review is to provide a succinct account of the range of existing evidence 
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that has explored and researched the use of interventions to address adherence with 
medication in older people. This review provides evidence of a scoping exercise that 
illustrated the range of published evidence pertinent to styles of interventions currently 
used to address adherence with medication in older people: information giving, patient 
behavioural approaches, the role and inclusion of health care professions in interventions 
and impact on health related outcomes.  The study drew on both UK and international 
literature in an attempt to illustrate for complexity and depth of the subject and the global 
nature of the subject matter.  
 
The search strategy involved the use of the following data bases: Google scholar, Cinahl, 
advanced Google Scholar, the Cochrane Library, Pubmed, Medline and British Nursing 
Index. Evidence was also generated from hand searching individual journals.  A defined 
search strategy was undertaken using the following terms: older people and medicines, 
elderly people, non adherence to medications, medication taking interventions, drug 
related  interventions, behavioural interventions, information focused interventions, 
combined medication interventions, single medication interventions. Search terms were  
used in combination. Research studies, RCTs, systematic reviews, exploratory studies 
using qualitative and quantitative research designs, Cochrane reviews, critical reviews of 
the literature and department of health reports were included in the review if they 
addressed the research question: which interventions improve adherence with medication 
in older people?  References were preferentially selected from a 12 year period from 
1996 to 2008 as it was felt that most relevant studies pertinent to the subject area would 
be located within this period and would reflect the currency of the available literature. 
 9
 
In total 892 references were identified electronically and by hand searching.  Abstracts 
and titles were scanned for relevance. In total 60 reports were selected for in-depth 
evaluation and, of these 20 research studies emerged that examined interventions used to 
improve adherence with medication in older people (Tables 1 & 2). These included 2 
RCTs, 7 Systematic reviews, 2 Cochrane reviews, 2 meta analyses, 3 critical reviews, 1 
qualitative study, 3 quantitative studies and 1 NCCSDO report.  
 
Studies were excluded if the sample population in studies was under 65 years of age, 
studies in which the sample population included a wide range of client ages as these 
studies would possibly not reflect the concerns of older people. Studies where the 
exploration of interventions did not focus on adherence with medication, or made no 
attempt to measure adherence with medication were excluded. In this review, the JADAD 
scoring system was used to analyse the quality and rigour of RCTs (Jadad et al., 1996). 
Using this scoring system, each RCT was summed to give an overall numerical score out 
of a possible 5. A score of 5 is indicated to be of the strongest and a score of 0 being the 
weakest indicator of quality. RCTs that achieved a score of 2 or less than 2 using the 
JADAD scoring system were excluded as they were felt to be of an inferior quality 
(Jadad et al., 1996) (Table 3). RCTS of short duration, less than three months were 
excluded as the short time scale would not be of sufficient length to measure the efficacy 
of interventions. Full text papers not written in English were excluded. Studies which 
focused on medication management interventions involving antipsychotic medication or 
patients with a history of psychotic or personality disorders were excluded as these 
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patients may have altered perceptions of reality which could adversely influence 
adherence with medication.  
 
Qualitative and quantitative papers were appraised using the Critical Appraisal Skills 
Programme (CASP, 1998) this approach allowed papers to be excluded in the review if 
they were judged to be insufficiently focused on older people, were interventions that did 
not address adherence to medication or studies that did not analyse data using qualitative 
methods.  The papers included in the review used a variety of research designs: pilot 
studies, meta-analyses, systematic reviews, questionnaire surveys, randomized controlled 
trials, cohort studies, and a range of exploratory quantitative studies, and a qualitative 
study reporting the syntheses of qualitative studies. As studies differed in interventions 
used, outcomes measures employed, time scale involved, and results, no meta analysis 
was possible. For this reason a narrative synthesis of the evidence was undertaken. This 
allowed subjective analysis and judgements of the relative merits of papers specific to the 
aim and objectives of the study and to what extent these were addressed. This analysis 
aimed to extract the salient aspects and merits of each study and their contribution to the 
subject area in order to present a substantial and coherent overview of the available 
evidence. The results also include the findings and inferences provided from an extensive 
NCCSSDO report on concordance, adherence and compliance in medication taking 
(Horne et al., 2005).  
 
Findings  
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 Studies that reported on specific interventions to improve and enhance adherence with 
medication were heterogeneous in terms of their quality, patient population, duration, 
outcome measures employed and follow-up duration schedules. Two RCTS were  
included: Nazareth et al., (2001) and Wu et al., (2006). Wu et al., (2006) achieved the 
highest JADAD score of 4, followed by a score of 3 for Nazareth et al., (2001).  
 
Quality concerns also existed with regard to the methodological rigour of systematic 
reviews. Higgins & Regan (2004) identified that few RCTs employed randomization, 
concealment allocation or power analysis methods. A definition of adherence was only 
provided in studies by Ware et al., (1991) and Wolfe & Schirm (1992). This finding 
concurs with a recent study (Williams et al., 2008).  Only three studies identified some 
statistical significant effect but had limited clinical outcome (Ware et al., 1991, Levens-
Lipton, 1994, Lowe et al., (2000). Significant findings relate to either cognitive support 
specific to the mechanics of medication delivery or education strategies and the use of 
physical aids to enhance adherence with medication. Ware et al., (1991) reported a 
significant improvement in adherence using blister calendar packs and cognitive support 
Data indicate that a significant improvement in adherence with medication with values of 
(86.7% vs. 66.7%) at discharge and (48.9% vs. 23.1% , p<0.05) at 3 months follow up.  
In Levens-Lipton & Bird, (1994) study, the significant data refer to the composite 
medication taking adherence score based on assessment and self reporting during patient 
interview. The following data were yielded with respect to improvement in adherence 
with medication (96.3% vs. 91.2%, p<0.05).  Lowe et al., (2000) also used an adherence 
score based on individual tablet count. Data indicate mean values of 91.3% (95% CI: 
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88.7, 93.9) versus mean of 79.5% (95% CI: 74.7, 84.3 p<0.0001). Although the data 
illustrate that significant effect were achieved the clinical outcome in terms of patient 
benefit or a considerable change in patient medication taking behavior appears to be 
limited.     
 
In the systematic review by Vergouwen et al., (2003) the heterogeneity of studies 
prevented any meaningful quantitative comparisons and therefore studies were 
summarized qualitatively. Even though educational intervention appeared to enhance 
adherence with anti-depressant medication, meaningful statistical analysis was not 
available.  
 
In contrast, Kriplani et al., (2007) assessed the effect size or standard deviation units for 
four types of interventions; informational; behavioural, family and social and combined. 
Effect size (ES) was assessed as being small (0.20 to <0.5), medium (0.50 to< 0.80) or 
large (>0.8) in order to provide an estimation of the true effect of the intervention.  The 
ES data varied depending on the intervention. Adherence increased most following 
behavioural interventions that reduced the medication dosing demands. Data in 3 studies 
indicated a large ES of (0.89-1.2).  Information interventions produced a variable effect 
on adherence. Evidence from 6 multi-sessional trials resulted in varied ES data of (0.3 -
1.13), and in combined interventions the ES data was (0.3-1.20). The ES data imply that 
combined interventions are more effective than informational interventions in improving 
medication adherence in patients with long term conditions.  
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The systematic review by Haynes et al., (1996), identified that only 7 out of 15 
intervention studies indicated some significant improvement in adherence with 
medication and only six out of the 15 intervention studies led to significant improvement 
in treatment outcomes.  Haynes comments that irrespective of the advancements in 
medical therapeutics and the multitude of highly rigorous RCTs, there has not been an 
equivalent response with regard to intervention RCTs. In fact there is a paucity of 
available studies. Many of these overestimate adherence due to the use of imprecise 
measurements such as self report or the small numbers of patients involved. Small scale 
studies usually lack the statistical power to detect clinical outcomes or important effects 
in 25% of patients.  
 
Evidence from current research contributed to the development of four key themes: 
patient behavioural approaches, information giving, health professional involvement, and 
health related outcomes (Table 4).  
 
Patient behavioral approaches 
Behavourial approaches have been used to assess medication taking behaviour and 
improve adherence with medication since 1990s. Approaches include: the use of 
specialized packaging such as blister and reminder packaging (Haynes et al; 1996, 
Newell et al., 1999, Higgins & Regan, 2004, Horne et al., 2005, Heneghan et al., 2007, 
medication reminder charts, multi-compartment compliance aids (Nunney & Raynor, 
1999, Heneghan et al., 2007), pill counting techniques (Ponnusankar et al., 2004, Roter et 
al., 1999) and pill boxes (Carlson et al., 2005).  Also self monitoring of pills, direct 
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observation of therapy, patient medication feedback (Carlson et al. 2005, Heneghan et al., 
2006, Schroeder et al., 2007) and self assessment of patients (Ponnusanakar et al., 2004).  
 
Blister packaging can be useful when combined with cognitive support (Higgins & 
Regan, 2004); independently its effect is variable. In studies with 1,137 participants only 
11% found blister packaging useful (Heneghan et al., 2007) which may be a reflection of 
the manufacturers packaging or dexterity related problems (Roter et al., 1998). 
 
Assessment of adherence has been undertaken through pill counting and counseling 
techniques to compile a medication score. Ponnusankar et al., (2004) reported compliance 
scores of 94±4.5 compared to 84.7±11.8 in usual care group and self reported estimates 
of compliance were 66.6% vs. 25% in the counseling and usual care groups, respectively. 
These data imply that pill boxes can improve adherence. However, not all patients can 
manage pill boxes or maintain a routine medication schedule (Carlson et al., 2005).  
Although  these are  interesting findings, inconsistency in measuring adherence using 
measures such as direct self report, pill counts, and direct questioning is reported and 
more uniform approaches are needed (Schroeder et al., 2007).    
 
 More success may be achieved by reducing the complexity of the medication regimen 
through reduction of the quantity of medicines administered in order to improve 
unintentional non-adherence (Nunney & Raynor, 1999, Schroeder et al., 2007). Such 
reductions can improve the adherence range from 8% to 19.6% and increase adherence 
rates (90% vs. 82%, p<0.01) (Schroeder et al. 2007) but it is debatable whether they 
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result in a change in clinical outcome (Kripalani et al., 2007).  In general RCTs poorly 
illustrate how behavioural approaches to medication adherence impact on patient 
behaviour. Horne et al., (2005) recommend that interventions should address patients’ 
perceptual and practical barriers (cognitive capacity) in order to evaluate their possible 
contribution to adherence.   
 
Information giving 
Patient education is a traditional approach to tackling the problem of adherence with 
medication in older people. Education is often implemented either as a single intervention 
involving one or several hours of instruction, accompanied by written instructions or as 
part of a complex or multiphase interventional approach (Roter et al., 1998, McDonald et 
al., 2002, Peterson et al., 2003, Higgins & Regan, 2004, Kripalani et al., 2007, Schroeder 
et al., 2007, Lu et al., 2008). The delivery of patient medication education is 
predominantly led by pharmacists where teaching is provided on an individual basis but 
can also take the form of self medication programmes and home visits (Higgins & Regan, 
2004, Lu et al., 2008).  Although pharmacist led teaching was considered effective, 
educational interventions were generally ineffective with reported ES scores of 0.11 
(95% CI: 0.06 -0.15) (Peterson et al., 2003), and a wide ranging (ES score of 0.35-1.13)  
in 6 out of 12 studies (Kripalani et al., 2007).  Even though Kripalani et al., (2007) 
reported that educational interventions delivered over multiple sessions can lead to some 
improvements in adherence, other reports are less favourable (MacDonald et al., 2002, 
Vergouwen et al., 2003, Schroeder et al., 2007, Lu et al., 2008). Educational interventions 
are largely unsuccessful, complex interventions are more efficient and productive and can 
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increase adherence by as much as 5% to 41% (Schroeder et al., 2007). Although Roter et 
al., (2004) concluded that direct education as a single intervention strategy was 
comparable to familial support and behavioural strategies; no individual intervention 
strategy was thought to be superior.   
 
Health care professional involvement 
 
Pharmacists have predominantly been recruited to intervention studies to provide advice 
and guidance to patients on how to manage their medicines (Nazareth et al., 2001,  
Higgins & Regan, 2004, Wu et al. 2006, Lu et al, 2008, Williams et al., 2008). These 
interventions vary in terms of design and pharmacist involvement and include; the use of 
tailored educational tools and the recognition of medication discrepancies (Williams et al, 
2008), telephone counseling service (Wu et al., 2006), educational programme or 
pharmacist-driven discharge planning programme and follow-up visit (Nazareth et al., 
2001), education plus icon-labeled medication containers plus therapeutic monitoring or 
the provision of collaborative care by pharmacists (Lu et al., 2008). Although the 
heterogeneity of study design makes it difficult to compare study outcomes, Wu et al., 
(2006) and Lu et al., (2008) agree that pharmacists involvement was beneficial as they 
helped to augment adherence with medication in older people.   
 
In some cases pharmacy involvement reduced mortality rates in older people evidenced 
by a reduction in the risk of death (Wu et al., 2006). In 1,011 patients the adjusted 
relative risk for death was 1.61, (95% CI: 1.05, 2.48, P= 0.029) and relative risk 2.87, 
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(95% CI: 1.80, 2.57, p<0.001) in patients with compliance scores of 34%-66% and 0-
33%, respectively (Wu et al., 2006). However, not all pharmacist–led interventions were 
beneficial. One only increased medication knowledge in older people (Nazareth et al., 
2001). In contrast, Higgins & Regan (2004) reported that pharmacists who lacked clinical 
experience impeded the success of educationally focused interventions. 
 
Health related outcomes 
The ultimate goal of adherence interventions is to improve health related outcomes. 
Evidence from systematic reviews indicate that health related improvement is variable 
with only 18 out of 49 RCTs indicating some improvement (Haynes, et al. 2005) and ES 
scores of (0.17 to 3.41) in 9 out of  20 RCTs  (Kipralani et al., 2007). The most effective 
RCTs are complex, multi-multifaceted, combined interventions which are more likely to 
address the multiple barriers to non-adherence and result in differences in compliance 
rates (van Eijken et al., 2003). However not all complex interventions are effective. 
Williams et al., (2008) found that the use of such interventions in chronic conditions were 
generally ineffective and weak.  There is some evidence that longer duration intervention 
studies, e.g. greater than 12 months strategies may reduce health care costs (Bernstein et 
al., 2001).  
  
 In their meta-ethnography of qualitative studies, Pound et al., (2005) stressed the need to 
prioritize and explore innovative measures that can provide new ways to address patient 
adherence with medication for long-term conditions and the safety of medicines.  Horne 
et al., (2005) also acknowledged that currently there is a paucity of good quality research 
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that has adequately addressed the complexity of adherence with medication especially in 
older people and common medical conditions with reported poor adherence with 
medication e.g. hypertension and heart failure. There has been some development in 
terms of research quality of intervention studies. The Medical Research Council (MRC) 
framework raises awareness of some of the methodological issues that are important 
when assessing adherence with medication in older people.  
  
Discussion  
 
Medicines management of the long term conditions that affect older people is an 
important aspect of the care they receive. The decision-making processes that underpin 
the treatment of long-term conditions and the use of medicines as therapeutic agents are 
extremely important for the success of any therapeutic intervention (Belcher et al., 2006, 
Braddock et al., 1997). For therapeutic interventions to operate successfully, the manner 
by which health care professionals communicate with patients is important and is a 
salient feature to the development of a concordant alliance with the patient (Pound et al;, 
2005). A key and essential feature of this alliance is the development of trust between the 
patient and the prescriber and the provision of opportunities for the patient to share their 
health beliefs, possible concerns about the relative dangers of medication and dependence 
and impressions of the role of medicines in the management of their condition (Horne & 
Weinman, 1999, Phatak & Thomas, 2006). It is equally important to examine the 
patients’ educational and personal needs to explore how influence the administration of 
their medicines (Jones, 2003, Pound et al., 2005).  Esposito (1995) and Elliott (2003) 
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have shown that education can have a significant impact on adherence with medication 
and can help to optimise adherence when used concurrently with the provision of written 
instructions. In this regard nurses have been found to be influential in providing patient 
centred medication education especially post discharge from hospital (Wolfe & Schirm, 
1992).  
 
Problems encountered when attempting to challenge non-adherent drug taking behaviour 
in the older person is the lack of a simple descriptor of the non-adherent patient and the 
difficulties encountered in actually measuring drug adherence. Quantitative interventions 
to assess adherence with medication, e.g. drug counts and electronic monitoring often fail 
to assess the reasons why patients are non-adherent with their medicines (Stimson, 1974, 
Horne et al., 2005) which is related to patient choice (Weintraub, 1990, Pound et al., 
2005).  
 
Interventions used to enhance patient / service user interaction e.g. pharmacist or nurse 
involvement can be effective however these interventions are resource intensive and their 
effectiveness may decline over time (Hawe & Higgins, 1990, Rich et al., 1996). 
Similarly, interventions employed to reduce patient barriers such as complexity of drug 
regimens or using blister packs have demonstrated favourable results (Ware et al., 1991, 
Heneghan et al., 2007). This approach can be used as a component of a combined or 
multiphase intervention strategy where each individual component is evaluated in order 
to express their individual benefit (Kripalani et al., 2007).  
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Few interventions evaluate and produce significant health related outcomes such as the 
extent of clinical effectiveness in conditions such as hypertension, asthma and 
schizophrenia (Haynes et al., 1996; 2005, Kripalani et al., 2007). There are inherent 
difficulties of using interventions to evaluate non-adherence with medication in elderly 
populations such as the impact of associated factors and their influence on therapeutic 
efficacy; perceptions of illness, need for medication, lifestyle patterns, alcohol use, diet, 
the appropriateness of prescribed medication regimens and the fact that many patients 
modify their drug regimens related to the significance of drug related side effects 
(Haynes et al., 2005, Horne et al., 2005).  
 
For interventions to be successful, they need to be both perceptual (addressing the 
patient’s beliefs and preferences) and practical related to factors that underpin intentional 
and unintentional non adherence such as motivation and cognitive capacity (Horne et al., 
2005). Interventions should be multifaceted, tailored to meet the needs of the patient, and 
sufficiently pragmatic to reduce unnecessary administration of drugs. They need to 
concurrently simplify the dosage regimen and take into consideration the patient 
perspective (Lipton & Bird, 1994, Dodds et al., 2000, Elliott, 2003, van Eijken et al., 
2003, Hughes, 2004). Multiphase intervention strategies are also needed to consider 
patient considerations from biological, sociological and psychological perspectives in 
order to address variables that can have an impact of non-adherence with medication 
(Krousel-Wood et al., 2005a).   
 
The RCTs reviewed did not use a theoretical framework to underpin their studies. There 
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is an absence of theoretical models that assess the complexities of adherence with 
medication in older people. Extensive theory development is needed to assist and 
enhance current understanding of the complexities of patterns of adherence, older 
patients’ preferences and actions specific to adherence with medication and to help guide 
the development of theoretical models that can be used in applied research. To achieve 
this, more in–depth qualitative studies are needed that examine older patient’s adherence 
with medication. 
 
Although the research framework such as the MRC model (Campbell et al., 2000) is 
available and can be used to assess and evaluate complex adherence interventions in a 
systematic way with identified stages that can be used to accumulate evidence of what 
works and why and also permits an evaluation of cost effectiveness (Horne et al. 2005, 
Elliott et al, 2005), however there is acknowledgement of the need for a theoretical frame 
to assist the development of intervention studies. 
 
The aim of this review was exploratory in that it aimed to present the available evidence 
from qualitative and quantitative studies that investigated the use of interventions to 
assess adherence with medication in older people. This review is limited in several ways. 
It did not permit a full exploration of studies with respect to their design, study 
population and their characteristics, an evaluation of the size of effects across studies, and 
an assessment of the possible factors that may limit the generalisability of the results of 
the review. Also despite extensive searching some studies may have been omitted. This 
may be due indexing of studies or the fact that intervention studies pertinent to older 
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people may traverse a wide range of diseases.  
 
Conclusion 
 
Non-adherence with medication in older people is a complex problem which is 
exaggerated by the lack of consensus on how adherence is measured in selective diseases 
(Hughes, 2004) and the absence of theoretical comprehension of the tenets of non-
adherent beheviour related to medication. A research framework is available in the form 
of the multi staged MRC model tool that can test the cost effectiveness of interventions 
(Campbell et al. 2000, Horne et al., 2005). According to Horne et al., (2005) a research 
priority is the need “to develop effective, efficient and equitable interventions to facilitate 
informed choice and optimal adherence to appropriate prescriptions where adherence 
matters most” p. 160.  In order to achieve this greater understanding of the underpinning 
knowledge of adherence with medication is required particularly in related to older 
people due to the quantity of medicines prescribed. 
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